ReviewInternational journal of molecular sciences2026
AI-Driven BCR Modeling for Precision Immunology.
Review in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The B cell receptor (BCR) repertoire captures an individual's immunological history and antigen-driven evolution within a vast, high-dimensional sequence space. Although bulk and single-cell adaptive immune receptor repertoire sequencing (AIRR-seq) now enables deep profiling of BCR diversity, interpreting these datasets remains challenging due to strong inter-individual heterogeneity, nonlinear sequence-structure-function relationships, dynamic clonal evolution, and the rarity of functionally relevant clones. Artificial intelligence (AI) provides a conceptual and computational framework for addressing these challenges. Here, we summarize how advanced deep learning architectures, including antibody-specific language models, graph neural networks (GNNs), and generative frameworks, uncover clonal topology, structural features, and antigen-binding semantics. We further highlight applications in cancer, infectious disease, and autoimmunity. Finally, we propose a closed-loop framework that integrates multimodal datasets, interpretable AI, and iterative experimental validation to advance predictive immunology and accelerate therapeutic antibody discovery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.